bamlanivimab
experimental antibody treatment for COVID-19
Facts
4 properties- Instance of
- active ingredient, antibody, medication[2][3]
- Described by source
- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19, LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection[5][6]
- Legal status (medicine)
- boxed warning[7]
🏷️ Also known as
en bamlanivimab
en LY3819253
en LY-CoV555
ar باملانيفاماب
ja バムラニヴィマブ
ja バムラニビマブ
ru Бамланивимаб
uk Бамланівімаб
zh 巴尼韋單抗
🔖 Identifiers · 10
- CAS Registry Number
- 2423943-37-5
- DrugBank ID
- DB15718
- Google Knowledge Graph ID
- /g/11mvmfhsw_
- Guide to Pharmacology Ligand ID
- 11325
- MedlinePlus drug identifier
- a620062
- RxNorm CUI
- 2463114
- UNII
- 45I6OFJ8QH
- WikiProjectMed ID
- Bamlanivimab
- World Health Organisation international non-proprietary name numeric ID
- 11876
🔗 Connections
Instance of 3
Belongs to 1
Developer 1
Legal status (medicine) 1
Press Enter · cited answer in seconds
0 sources
Summary
bamlanivimab is an active ingredient[1].